Focal adhesion kinase (125 kDa form; pp125(FAK)) is a widely expressed
non-receptor tyrosine kinase that is implicated in integrin-mediated
signal transduction. We have identified a novel means of pp125(FAK) re
gulation in human platelets, in which this kinase undergoes sequential
proteolytic modification from the native 125 kDa form to 90, 45 and 4
0 kDa fragments in thrombin-, collagen- and ionophore A23187-stimulate
d platelets. The proteolysis of pp125(FAK) was prevented by pretreatin
g platelets with the calpain inhibitors calpeptin or calpain inhibitor
-1, and was reproduced in vitro by incubating immunoprecipitated pp125
(FAK) with purified calpain. Proteolysis of pp125(FAK) resulted in a d
ramatic reduction in its autokinase activity and led to its dissociati
on from the cytoskeletal fraction of platelets. These studies define a
novel signal-terminating role for calpain, wherein proteolytic modifi
cation of pp125(FAK) attenuates its autokinase activity and induces it
s subcellular relocation within the cell.